Search for Clinical Trial Results
Scleroderma, Systemic - 20 Studies Found
Status | Study |
Recruiting |
Study Name: Subcutaneous Injection of Autologous Adipose Tissue-derived Stromal Vascular Fraction Into the Fingers of Patients With Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2015-08-31 Interventions:
|
Not yet recruiting |
Study Name: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study Condition: Scleroderma, Systemic Date: 2017-03-23 Interventions:
|
Completed |
Study Name: Efficacy and Safety of Imatinib in Scleroderma Condition:
|
Completed |
Study Name: Oral Manifestations of Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2015-02-18 Interventions: Radiation: Cone Beam Computed Tomography (CBCT) |
Recruiting |
Study Name: Scleroderma Registry & Repository at the Hospital for Special Surgery Condition: Scleroderma Date: 2012-08-01 |
Completed |
Study Name: Nilotinib in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2010-07-01 Interventions: Drug: Nilotinib (Tasigna) Patients will be treated with Nilotinib 400 mg two times a day for 6 months. |
Active, not recruiting |
Study Name: Taking Charge of Systemic Sclerosis Condition: Scleroderma Date: 2015-05-22 Interventions:
|
Completed |
Study Name: Morbidity and Mortality Follow Up for the Scleroderma Lung Study Condition: Scleroderma Date: 2013-01-04 Interventions: Other: Followup survey |
Completed |
Study Name: Imatinib Mesylate (Gleevec) in the Treatment of Systemic Sclerosis Condition: Systemic Sclerosis Date: 2007-11-07 Interventions: Drug: Imatinib Mesylate In initial phase, patients will be treated with Gleevec 400 mg daily for 12 mont |
Completed |
Study Name: Angiogenic/Angiostatic Mediators in Patients With Systemic Sclerosis Condition: Systemic Sclerosis Date: 2008-04-25 |